Results 1 to 20 of 20
Page 1 of 2
TypeTitleAuthor(s)YearViews
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer modelsMa, BBY; Lui, VWY; Hui, CWC; Lau, CPY; Wong, CH; Hui, EP; Ng, MHL; Cheng, SH; Tsao, SW; Tsang, C-M; Cheung, CSF; Ho, K; Chan, ATC201423
 
Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong KongChiu, MLS; Hu, M; Ng, MHL; Yeung, CK; Chan, JCY; Chang, MM; Cheng, SH; Li, L; Tomlinson, B2012118
 
Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinomaZhou, Q; Lui, VWY; Lau, CPY; Cheng, SH; Ng, MHL; Cai, Y; Chan, SL; Yeo, W201220
 
Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activationHong, B; Lui, VWY; Hui, EP; Ng, MHL; Cheng, SH; Sung, FL; Tsang, CM; Tsao, SW; Chan, ATC2011272
 
Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growthChen, J; Zhang, B; Wong, N; Lo, AWI; To, KF; Chan, AWH; Ng, MHL; Ho, CYS; Cheng, SH; Lai, PBS; Yu, J; Ng, HK; Ling, MT; Huang, AL; Cai, XF; Ko, BCB2011146
 
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell deathLui, VWY; Wong, EYL; Ho, K; Ng, PKS; Lau, CPY; Tsui, SKW; Tsang, CM; Tsao, SW; Cheng, SH; Ng, MHL; Ng, YK; Lam, EKY; Hong, B; Lo, KW; Mok, TSK; Chan, ATC; Mills, GB2011359
 
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinomaHui, EP; Lui, VWY; Wong, CSC; Ma, BBY; Lau, CPY; Cheung, CSF; Ho, K; Cheng, S-H; Ng, MHL; Chan, ATC201124
 
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1Hong, B; Lui, VWY; Hui, EP; Lu, Y; Leung, HSY; Wong, EYL; Cheng, S-H; Ng, MHL; Mills, GB; Chan, ATC201026
 
Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cellsLui, VWY; Lau, CPY; Ho, K; Ng, MHL; Cheng, SH; Tsao, SW; Tsang, CM; Lei, KIK; Chan, AT; Mok, TSK2010105
 
A small molecule inhibitor of NF-κB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cellsWong, JHT; Lui, VWY; Umezawa, K; Ho, Y; Wong, EYL; Ng, MHL; Cheng, SH; Tsang, CM; Tsao, SW; Chan, ATC2010348
 
An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulationLui, VWY; Lau, CPY; Cheung, CSF; Ho, K; Ng, MHL; Cheng, SH; Hong, B; Tsao, SW; Tsang, CM; Lei, KIK; Yamasaki, Y; Mita, A; Chan, ATC2010349
 
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell linesMa, BBY; Lui, VWY; Hui, EP; Lau, CPY; Ho, K; Ng, MHL; Cheng, SH; Tsao, SW; Chan, ATC2010342
 
KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomasCheng, Y; Geng, H; Cheng, SH; Liang, P; Bai, Y; Li, J; Srivastava, G; Ng, MHL; Fukagawa, T; Wu, X; Chan, ATC; Tao, Q2010135
 
Erratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7)Ma, BBY; Lui, VWY; Poon, FF; Wong, SCC; To, KF; Wong, E; Chen, H; Lo, KW; Tao, Q; Ng, MHL; Cheng, SH; Chan, ATC2010512
 
Alisol B, a novel inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump, induces autophagy, endoplasmic reticulum stress, and apoptosisLaw, BYK; Wang, M; Ma, DL; AlMousa, F; Michelangeli, F; Cheng, SH; Ng, MHL; To, KF; Mok, AYF; Ko, RYY; Lam, SK; Chen, F; Che, CM; Chiu, P; Ko, BCB20101,234
 
The familial risk and HLA susceptibility among narcolepsy patients in Hong Kong ChineseChen, L; Fong, SYY; Lam, CW; Tang, NLS; Ng, MHL; Li, AM; Ho, CKW; Cheng, SH; Lau, KM; Wing, YK200783
 
Improved outcome of acute lymphoblastic leukaemia treated by delayed intensification in Hong Kong children: HKALL 97 studyLi, CK; Chik, KW; Ha, SY; Lee, ACW; Yuen, HL; Ling, SC; Lee, V; Chan, GCF; Shing, MMK; Chan, LC; Ng, MHL2006402
 
Alterations of RAS signalling in Chinese multiple myeloma patients: Absent BRAF and rare RAS mutations, but frequent inactivation of RASSF1A by transcriptional silencing or expression of a non-functional variant transcriptNg, MHL; Lau, KM; Wong, WS; To, KW; Cheng, SH; Tsang, KS; Chan, NPH; Kho, BCS; Lo, KW; Tong, JHM; Lam, CW; Chan, JCW2003117
 
Cytogenetics of Acute Lymphoblastic Leukaemia (ALL) in Chinese Children: Response to TreatmentLi, CK; Luk, CW; Chan, GCF; Lee, ACW; Ling, SC; Ng, MHL; Chan, LC; Chik, KW200186
 
Acute myeloid leukemia following psoralen with ultraviolet A therapy: A fluorescence in situ hybridization studyKwong, YL; Au, WY; Ng, MHL; Chan, LC; Au, TS199791
 
Page 1 of 2
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download